The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VYCO · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | MSA | ELTP | WST | VYCO |
|---|---|---|---|---|
| Moat Score (0–100) | 74 | 75 (highest) | 75 (highest) | 74 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 90 (highest) | 90 (highest) | 44 | 70 |
| Pricing power | 77 | 71 | 54 | 100 (highest) |
| Returns on capital | 60 | 80 | 91 (highest) | — |
| Balance-sheet safety | 66 | 73 | 100 (highest) | 100 (highest) |
| Capital discipline | 74 | 60 | 83 (highest) | 24 |
| Price vs. high estimate | 105% above high estimate (largest discount to high estimate) | 293% above high estimate | 124% above high estimate | No price data |
| Market cap | $6.8B | $420M | $23.6B | $2.3M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2026 | FY2025 | FY2025 |